0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
China Adrenoleukodystrophy Drugs Market Report & Forecast 2021-2027
Published Date: August 2021
|
Report Code: QYRE-Auto-29S5308
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
China Adrenoleukodystrophy Drugs Market Report Forecast 2021 2027

China Adrenoleukodystrophy Drugs Market Report & Forecast 2021-2027

Code: QYRE-Auto-29S5308
Report
August 2021
91 Pages
QYResearch
Region: Global, China,
Description
Table of Content
Tables & Figures
China Adrenoleukodystrophy Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
China Adrenoleukodystrophy Drugs Market Segment Percentages, By Type, 2020 (%)
Hormone Replacement
Transplant
Others
China Adrenoleukodystrophy Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
China Adrenoleukodystrophy Drugs Market Segment Percentages, By Application, 2020 (%)
Childhood Cerebral ALD
Adrenomyeloneuropathy (AMN)
Addison-only
Others
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adrenoleukodystrophy Drugs revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Adrenoleukodystrophy Drugs revenues share in China market, 2020 (%)
Key companies Adrenoleukodystrophy Drugs sales in China market, 2016-2021 (Estimated), (K Units)
Key companies Adrenoleukodystrophy Drugs sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

Bluebird Bio Inc
NeuroVia, Inc.
Orpheris, Inc.
Minoryx
MedDay Pharmaceuticals
1 Introduction to Research & Analysis Reports
1.1 Adrenoleukodystrophy Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Adrenoleukodystrophy Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Adrenoleukodystrophy Drugs Overall Market Size
2.1 China Adrenoleukodystrophy Drugs Market Size: 2021 VS 2027
2.2 China Adrenoleukodystrophy Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 China Adrenoleukodystrophy Drugs Sales: 2016-2027
3 Company Landscape
3.1 Top Adrenoleukodystrophy Drugs Players in China Market
3.2 Top China Adrenoleukodystrophy Drugs Companies Ranked by Revenue
3.3 China Adrenoleukodystrophy Drugs Revenue by Companies
3.4 China Adrenoleukodystrophy Drugs Sales by Companies
3.5 China Adrenoleukodystrophy Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Adrenoleukodystrophy Drugs Companies in China Market, by Revenue in 2020
3.7 Manufacturers Adrenoleukodystrophy Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Adrenoleukodystrophy Drugs Players in China Market
3.8.1 List of Tier 1 Adrenoleukodystrophy Drugs Companies in China
3.8.2 List of Tier 2 and Tier 3 Adrenoleukodystrophy Drugs Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Adrenoleukodystrophy Drugs Market Size Markets, 2021 & 2027
4.1.2 Hormone Replacement
4.1.3 Transplant
4.1.4 Others
4.2 By Type - China Adrenoleukodystrophy Drugs Revenue & Forecasts
4.2.1 By Type - China Adrenoleukodystrophy Drugs Revenue, 2016-2021
4.2.2 By Type - China Adrenoleukodystrophy Drugs Revenue, 2022-2027
4.2.3 By Type - China Adrenoleukodystrophy Drugs Revenue Market Share, 2016-2027
4.3 By Type - China Adrenoleukodystrophy Drugs Sales & Forecasts
4.3.1 By Type - China Adrenoleukodystrophy Drugs Sales, 2016-2021
4.3.2 By Type - China Adrenoleukodystrophy Drugs Sales, 2022-2027
4.3.3 By Type - China Adrenoleukodystrophy Drugs Sales Market Share, 2016-2027
4.4 By Type - China Adrenoleukodystrophy Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Adrenoleukodystrophy Drugs Market Size, 2021 & 2027
5.1.2 Childhood Cerebral ALD
5.1.3 Adrenomyeloneuropathy (AMN)
5.1.4 Addison-only
5.1.5 Others
5.2 By Application - China Adrenoleukodystrophy Drugs Revenue & Forecasts
5.2.1 By Application - China Adrenoleukodystrophy Drugs Revenue, 2016-2021
5.2.2 By Application - China Adrenoleukodystrophy Drugs Revenue, 2022-2027
5.2.3 By Application - China Adrenoleukodystrophy Drugs Revenue Market Share, 2016-2027
5.3 By Application - China Adrenoleukodystrophy Drugs Sales & Forecasts
5.3.1 By Application - China Adrenoleukodystrophy Drugs Sales, 2016-2021
5.3.2 By Application - China Adrenoleukodystrophy Drugs Sales, 2022-2027
5.3.3 By Application - China Adrenoleukodystrophy Drugs Sales Market Share, 2016-2027
5.4 By Application - China Adrenoleukodystrophy Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Bluebird Bio Inc
6.1.1 Bluebird Bio Inc Corporation Information
6.1.2 Bluebird Bio Inc Overview
6.1.3 Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales and Revenue in China Market (2016-2021)
6.1.4 Bluebird Bio Inc Adrenoleukodystrophy Drugs Product Description
6.1.5 Bluebird Bio Inc Recent Developments
6.2 NeuroVia, Inc.
6.2.1 NeuroVia, Inc. Corporation Information
6.2.2 NeuroVia, Inc. Overview
6.2.3 NeuroVia, Inc. Adrenoleukodystrophy Drugs Sales and Revenue in China Market (2016-2021)
6.2.4 NeuroVia, Inc. Adrenoleukodystrophy Drugs Product Description
6.2.5 NeuroVia, Inc. Recent Developments
6.3 Orpheris, Inc.
6.3.1 Orpheris, Inc. Corporation Information
6.3.2 Orpheris, Inc. Overview
6.3.3 Orpheris, Inc. Adrenoleukodystrophy Drugs Sales and Revenue in China Market (2016-2021)
6.3.4 Orpheris, Inc. Adrenoleukodystrophy Drugs Product Description
6.3.5 Orpheris, Inc. Recent Developments
6.4 Minoryx
6.4.1 Minoryx Corporation Information
6.4.2 Minoryx Overview
6.4.3 Minoryx Adrenoleukodystrophy Drugs Sales and Revenue in China Market (2016-2021)
6.4.4 Minoryx Adrenoleukodystrophy Drugs Product Description
6.4.5 Minoryx Recent Developments
6.5 MedDay Pharmaceuticals
6.5.1 MedDay Pharmaceuticals Corporation Information
6.5.2 MedDay Pharmaceuticals Overview
6.5.3 MedDay Pharmaceuticals Adrenoleukodystrophy Drugs Sales and Revenue in China Market (2016-2021)
6.5.4 MedDay Pharmaceuticals Adrenoleukodystrophy Drugs Product Description
6.5.5 MedDay Pharmaceuticals Recent Developments
7 China Adrenoleukodystrophy Drugs Production Capacity, Analysis
7.1 China Adrenoleukodystrophy Drugs Production Capacity, 2016-2027
7.2 Adrenoleukodystrophy Drugs Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Adrenoleukodystrophy Drugs Supply Chain Analysis
9.1 Adrenoleukodystrophy Drugs Industry Value Chain
9.2 Adrenoleukodystrophy Drugs Upstream Market
9.3 Adrenoleukodystrophy Drugs Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Adrenoleukodystrophy Drugs Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
    Table 1. Key Players of Adrenoleukodystrophy Drugs in China Market
    Table 2. Top Adrenoleukodystrophy Drugs Players in China Market, Ranking by Revenue (2019)
    Table 3. China Adrenoleukodystrophy Drugs Revenue by Companies, (US$, Mn), 2016-2021
    Table 4. China Adrenoleukodystrophy Drugs Revenue Share by Companies, 2016-2021
    Table 5. China Adrenoleukodystrophy Drugs Sales by Companies, (K Units), 2016-2021
    Table 6. China Adrenoleukodystrophy Drugs Sales Share by Companies, 2016-2021
    Table 7. Key Manufacturers Adrenoleukodystrophy Drugs Price (2016-2021) & (US$/Unit)
    Table 8. Manufacturers Adrenoleukodystrophy Drugs Product Type
    Table 9. List of Tier 1 Adrenoleukodystrophy Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Tier 2 and Tier 3 Adrenoleukodystrophy Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. Major Manufacturers of Hormone Replacement
    Table 12. Major Manufacturers of Transplant
    Table 13. By Type – China Adrenoleukodystrophy Drugs Revenue, (US$, Mn), 2021 & 2027
    Table 14. By Type - China Adrenoleukodystrophy Drugs Revenue (US$, Mn), 2016-2021
    Table 15. By Type - China Adrenoleukodystrophy Drugs Revenue (US$, Mn), 2022-2027
    Table 16. By Type - China Adrenoleukodystrophy Drugs Sales (K Units), 2016-2021
    Table 17. By Type - China Adrenoleukodystrophy Drugs Sales (K Units), 2022-2027
    Table 18. By Application – China Adrenoleukodystrophy Drugs Revenue, (US$, Mn), 2021 VS 2027
    Table 19. By Application - China Adrenoleukodystrophy Drugs Revenue (US$, Mn), 2016-2021
    Table 20. By Application - China Adrenoleukodystrophy Drugs Revenue (US$, Mn), 2022-2027
    Table 21. By Application - China Adrenoleukodystrophy Drugs Sales (K Units), 2016-2021
    Table 22. By Application - China Adrenoleukodystrophy Drugs Sales (K Units), 2022-2027
    Table 23. Bluebird Bio Inc Corporation Information
    Table 24. Bluebird Bio Inc Description and Major Businesses
    Table 25. Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 26. Bluebird Bio Inc Adrenoleukodystrophy Drugs Product
    Table 27. Bluebird Bio Inc Recent Developments
    Table 28. NeuroVia, Inc. Corporation Information
    Table 29. NeuroVia, Inc. Description and Major Businesses
    Table 30. NeuroVia, Inc. Adrenoleukodystrophy Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 31. NeuroVia, Inc. Adrenoleukodystrophy Drugs Product
    Table 32. NeuroVia, Inc. Recent Developments
    Table 33. Orpheris, Inc. Corporation Information
    Table 34. Orpheris, Inc. Description and Major Businesses
    Table 35. Orpheris, Inc. Adrenoleukodystrophy Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 36. Orpheris, Inc. Adrenoleukodystrophy Drugs Product
    Table 37. Orpheris, Inc. Recent Developments
    Table 38. Minoryx Corporation Information
    Table 39. Minoryx Description and Major Businesses
    Table 40. Minoryx Adrenoleukodystrophy Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 41. Minoryx Adrenoleukodystrophy Drugs Product
    Table 42. Minoryx Recent Developments
    Table 43. MedDay Pharmaceuticals Corporation Information
    Table 44. MedDay Pharmaceuticals Description and Major Businesses
    Table 45. MedDay Pharmaceuticals Adrenoleukodystrophy Drugs Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021)
    Table 46. MedDay Pharmaceuticals Adrenoleukodystrophy Drugs Product
    Table 47. MedDay Pharmaceuticals Recent Developments
    Table 48. Adrenoleukodystrophy Drugs Production Capacity (K Units) of Key Manufacturers in China Market, 2019-2021 (K Units)
    Table 49. China Adrenoleukodystrophy Drugs Capacity Market Share of Key Manufacturers, 2019-2021
    Table 50. Adrenoleukodystrophy Drugs Market Opportunities & Trends in China Market
    Table 51. Adrenoleukodystrophy Drugs Market Drivers in China Market
    Table 52. Adrenoleukodystrophy Drugs Market Restraints in China Market
    Table 53. Adrenoleukodystrophy Drugs Raw Materials
    Table 54. Adrenoleukodystrophy Drugs Raw Materials Suppliers in China Market
    Table 55. Typical Adrenoleukodystrophy Drugs Downstream
    Table 56. Adrenoleukodystrophy Drugs Downstream Clients in China Market
    Table 57. Adrenoleukodystrophy Drugs Distributors and Sales Agents in China Market
List of Figures
    Figure 1. Adrenoleukodystrophy Drugs Product Picture
    Figure 2. Adrenoleukodystrophy Drugs Segment by Type
    Figure 3. Adrenoleukodystrophy Drugs Segment by Application
    Figure 4. China Adrenoleukodystrophy Drugs Market Overview: 2020
    Figure 5. China Adrenoleukodystrophy Drugs Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. China Adrenoleukodystrophy Drugs Revenue, 2016-2027 (US$, Mn)
    Figure 7. Adrenoleukodystrophy Drugs Sales in China Market: 2016-2027 (K Units)
    Figure 8. The Top 3 and 5 Players Market Share by Adrenoleukodystrophy Drugs Revenue in 2020
    Figure 9. Hormone Replacement Product Picture
    Figure 10. Transplant Product Picture
    Figure 11. Others Product Picture
    Figure 12. By Type - China Adrenoleukodystrophy Drugs Sales Market Share, 2016-2027
    Figure 13. By Type - China Adrenoleukodystrophy Drugs Revenue Market Share, 2016-2027
    Figure 14. By Type - China Adrenoleukodystrophy Drugs Price (US$/Unit), 2016-2027
    Figure 15. Childhood Cerebral ALD
    Figure 16. Adrenomyeloneuropathy (AMN)
    Figure 17. Addison-only
    Figure 18. Others
    Figure 19. By Application - China Adrenoleukodystrophy Drugs Sales Market Share, 2016-2027
    Figure 20. By Application - China Adrenoleukodystrophy Drugs Revenue Market Share, 2016-2027
    Figure 21. By Application - China Adrenoleukodystrophy Drugs Price (US$/Unit), 2016-2027
    Figure 22. Bluebird Bio Inc Adrenoleukodystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 23. NeuroVia, Inc. Adrenoleukodystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 24. Orpheris, Inc. Adrenoleukodystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 25. Minoryx Adrenoleukodystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 26. MedDay Pharmaceuticals Adrenoleukodystrophy Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 27. China Adrenoleukodystrophy Drugs Production Capacity (K Units), 2016-2027
    Figure 28. Adrenoleukodystrophy Drugs Industry Value Chain
    Figure 29. Marketing Channels
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3400
This license allows only one user to access the PDF.

Electronic (PDF)
$5100
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$6800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

China Antimicrobial Peptides Market Report Forecast 2021 2027
China Antimicrobial Peptides Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-34I759
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Automated Cell Culture Market Report Forecast 2021 2027
China Automated Cell Culture Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Othe-462
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Aprotinin Market Report Forecast 2021 2027
China Aprotinin Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-10191
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Automatic Checkweigher Market Report Forecast 2021 2027
China Automatic Checkweigher Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-3M4433
Sat Oct 02 00:00:00 UTC 2021

Add to Cart